Connor, Clark & Lunn Investment Management (CC&L)
PAHC icon

Connor, Clark & Lunn Investment Management (CC&L)’s Phibro Animal Health PAHC Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,066
Closed -$182K – 1606
2024
Q1 		$182K Buy
+14,066
New +$169K ﹤0.01% 1410
2020
Q3 		– Sell
-20,292
Closed -$533K – 1069
2020
Q2 		$533K Buy
+20,292
New +$504K ﹤0.01% 745

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s PAHC Position: Q2 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Phibro Animal Health (PAHC) in Q2 2024, closing a stake of 14,066 shares — an estimated $182K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PAHC in Q2 2020 and held it in 2 quarters. The position peaked at $533K in Q2 2020. 141 funds tracked by Wall St. Rank hold PAHC as of Q2 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Phibro Animal Health position as of Q2 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 14,066 Phibro Animal Health shares in Q2 2024, an estimated $182K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Phibro Animal Health in Q2 2020 and held it in 2 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Phibro Animal Health position peaked at $533K in Q2 2020.
  • 141 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2024, filed 9 Aug 2024.